既往药物治疗对晚发性难治性抑郁序贯双侧θ爆发与标准双侧rTMS缓解率的影响
基于FOUR-D试验数据,分析既往药物试验数目和类别对两种rTMS缓解率的影响。既往≤1次试验者缓解率为43.9%,2次为26.5%,≥3次为24.6%(χ²=6.36,d.f.=2,P=0.04)。在晚发性抑郁中更早使用rTMS可能带来更好结局。
要点
- 既往药物试验≤1次者rTMS缓解率43.9%,高于2次者26.5%和≥3次者24.6%。
- 三组缓解率差异有统计学意义(χ²=6.36,d.f.=2,P=0.04)。
- 晚发性抑郁中更早启用rTMS可能改善缓解结局。
核心结论
- 在晚发性难治性抑郁中,既往药物试验次数较少者接受rTMS的缓解率更高。
- 更早使用rTMS可能带来更好的临床结局。
研究设计与样本
- 基于FOUR-D试验数据的分析,比较序贯双侧θ爆发刺激(TBS)与标准双侧重复经颅磁刺激(rTMS)的缓解率。
- 按既往药物试验数目和类别分层分析缓解率。
主要发现
- 既往≤1次药物试验者缓解率为43.9%。
- 既往2次药物试验者缓解率为26.5%。
- 既往≥3次药物试验者缓解率为24.6%。
- 三组缓解率比较χ²=6.36,d.f.=2,P=0.04。
关键数值与推荐
- 缓解率按既往药物试验次数分层:≤1次43.9%,2次26.5%,≥3次24.6%。
- 组间差异统计学显著:χ²=6.36,d.f.=2,P=0.04。
临床怎么用
- 对晚发性抑郁患者,考虑在既往药物试验次数较少时更早启用rTMS。
- 既往药物试验次数可作为rTMS疗效的参考因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Repetitive transcranial magnetic stimulation (rTMS) is used for treatment of late-life depression. In the FOUR-D study, sequential bilateral theta-burst stimulation (TBS) had comparable remission rates to standard bilateral rTMS. Data were analysed from the FOUR-D trial to compare remission rates between two types of rTMS based on the number and class of prior medication trials. The remission rate was higher in participants with ≤1 previous trial (43.9%) than in participants with 2 previous trials (26.5%) or ≥3 previous trials (24.6%; χ² = 6.36, d.f. = 2, P = 0.04). Utilising rTMS earlier in late-life depression may lead to better outcomes.
引用
- Wathra RA, Mulsant BH, Daskalakis ZJ, et al. Effect of prior pharmacotherapy on remission with sequential bilateral theta-burst versus standard bilateral repetitive transcranial magnetic stimulation in treatment-resistant late-life depression. Br J Psychiatry. 2023. PMID: 37334540. doi:10.1192/bjp.2023.81
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。